The FDA has approved a biosimilar of pertuzumab which is indicated for multiple breast cancer settings. The FDA has approved ...

All In Solutions Detox, a leading addiction treatment center in Southern California, has enhanced its client intake process ...

The 12 businesses were shut down by police during an 18-month operation, according to the Morgan Hill Police Department. The ...

"This van will operate at least five days a week transporting up to 16 people at a time going out and doing trash pickup on ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to tinostamustine, an investigational therapeutic from Purdue Pharma L.P., for the treatment of patients with malignant ...

FDA Fast Track designation -- The BRTX-100 program was granted Fast Track status by the FDA for chronic lumbar disc disease ...

A single intravitreal injection of 4D-150 helped patients with wet age-related macular degeneration maintain visual acuity ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. | Third ...

Near-term applications include combinations with kinase inhibitors (KIs) that achieve enhanced concentration at target sites ...